scispace - formally typeset
Open AccessJournal ArticleDOI

Improving and Accelerating Drug Development for Nervous System Disorders

Reads0
Chats0
TLDR
To accelerate nervous system drug development, the Institute of Medicine's Forum on Neuroscience and Nervous System Disorders has hosted a series of public workshops that brought together representatives of industry, government, academia, and patient groups to discuss these challenges and offer potential strategies to improve the translational neuroscience.
About
This article is published in Neuron.The article was published on 2014-11-05 and is currently open access. It has received 162 citations till now. The article focuses on the topics: Drug development.

read more

Citations
More filters
Journal ArticleDOI

IID 2018 update: context-specific physical protein-protein interactions in human, model organisms and domesticated species.

TL;DR: The Integrated Interactions Database (IID) provides one of the most comprehensive sets of context-specific human PPI networks, including networks for 133 tissues, 91 disease conditions, and many other contexts, and now supports topology and enrichment analyses of returned networks.
Journal ArticleDOI

The future of rodent models in depression research.

TL;DR: This Review examines the importance of sex as a biological variable and the controversial idea of intergenerational and transgenerational transmission of depressive-like traits, and discusses how genetic and circuit-dissection techniques might be used to refine existing models and generate new ones.
Journal ArticleDOI

The NIMH experimental medicine initiative.

TL;DR: The development of devices and psychosocial treatments in psychopharmacology over the past decade appears to have stalled after four decades of exuberant growth.
References
More filters
Journal ArticleDOI

Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010

Theo Vos, +363 more
- 15 Dec 2012 - 
TL;DR: Prevalence and severity of health loss were weakly correlated and age-specific prevalence of YLDs increased with age in all regions and has decreased slightly from 1990 to 2010, but population growth and ageing have increased YLD numbers and crude rates over the past two decades.
Journal ArticleDOI

Biological insights from 108 schizophrenia-associated genetic loci

Stephan Ripke, +354 more
- 24 Jul 2014 - 
TL;DR: Associations at DRD2 and several genes involved in glutamatergic neurotransmission highlight molecules of known and potential therapeutic relevance to schizophrenia, and are consistent with leading pathophysiological hypotheses.
Journal ArticleDOI

Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease

Jean-Charles Lambert, +215 more
- 01 Dec 2013 - 
TL;DR: In addition to the APOE locus (encoding apolipoprotein E), 19 loci reached genome-wide significance (P < 5 × 10−8) in the combined stage 1 and stage 2 analysis, of which 11 are newly associated with Alzheimer's disease.
Journal ArticleDOI

How to improve R&D productivity: the pharmaceutical industry's grand challenge

TL;DR: A detailed analysis based on comprehensive, recent, industry-wide data is presented to identify the relative contributions of each of the steps in the drug discovery and development process to overall R&D productivity and propose specific strategies that could have the most substantial impact in improving R &D productivity.
Journal ArticleDOI

Alzheimer disease in the United States (2010-2050) estimated using the 2010 census.

TL;DR: The number of people in the United States with AD dementia will increase dramatically in the next 40 years unless preventive measures are developed.
Related Papers (5)
Trending Questions (2)
What are the problems in the idea that understanding neural circuits of disorders will advance drug development?

The paper does not specifically mention the idea that understanding neural circuits of disorders will advance drug development.

Why understanding neural circuits of disorders will not advance drug development?

The paper does not provide a direct answer to the query. The paper discusses the importance of understanding neural circuits and characterizing neural connectivity for advancing basic scientific knowledge about diverse diseases. However, it does not specifically address why understanding neural circuits of disorders will not advance drug development.